Select country change
Shopping cart (0 , 0,00 ) Menu Search
Distributed product

Positive control: Humanized IgG Monoclonal Antibody against SARS-CoV-2 S1RBD

  • Type:Control Set
  • Other names:Severe acute respiratory syndrome coronavirus 2 nucleocapsid, 2019 novel coronavirus nucleoprotein, SARS-CoV-2 NP, SARS-CoV-2 N protein, COVID-19
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price


New 41A236 220μl per vial
PubMed Product Details
Technical Data

Type

Control Set

Applications

COVID-19

Sample Requirements

100 ul/well

Storage/Expiration

Store the lyophilized antibody at -20°C for long-term storage. After reconstitution, store at 4 degrees for short-term storage (3 days) or store in aliquots at -80 degrees for long-term storage. Avoid frequent freeze-thaw cycles.

Summary

Features

  • This product is intended for for research use only.
  • After reconstitution, it is ready-to-use positive control for Human Anti-SARS-CoV-2 S1RBD IgG ELISA.

Research topic

COVID-19

Summary

Since December 2019, outbreak of SARS-CoV-2 (COVID-19) infection has become a major epidemic threat in China and brought back the attention of pathogenic coronavirus to the spotlight. Nucleocapsid protein (NP) is the most abundant protein on the helical nucleocapsid of coronaviruses, which envelopes the entire genomic RNA. NP also interacts with other viron structural proteins to play important roles during host cell entry and virus particle assembly and release. Anti-NP antibodies have been shown to be the earliest and the most predominant antibodies detectable in patient’s blood samples after coronavirus infection. Human anti-COVID-19 nucleocapsid protein (NP) IgG ELISA kit is a highly sensitive and specific ELISA kit for the precision detection and quantitative measurement of titres of anti-NP IgG class antibodies in human serum.

Related Products Docs